title: Comment on: Treatment of EBV-Associated Nodular Sclerosing Hodgkin Lymphoma in a Patient With Ataxia Telangiectasia With Brentuximab Vedotin and Reduced COPP Plus Rituximab.
authors.affiliation: Klinik für Kinder-und Jugendmedizin, Allergologie, Pneumologie und Mukoviszidose, Universitätsklinikum Frankfurt, Frankfurt am Main, 60590, Germany.
authors.forename: Stefan
authors.initials: S
authors.lastname: Zielen
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001260:Ataxia Telangiectasia / Q000188:drug therapy*; D020031:Epstein-Barr Virus Infections / Q000188:drug therapy*; D004854:Herpesvirus 4, Human; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D018796:Immunoconjugates / Q000008:administration & dosage*; D008297:Male; D000069283:Rituximab / Q000008:administration & dosage*
chemical_list: D018796:Immunoconjugates; D000069283:Rituximab